[ Editorials | Letters | Selected Articles | Departments and Series | Patient Handouts | Index ]

Primary Care Annual Subject Index 2001

[ Subject | Author ]

Adolescence
Alternative medicine
Breast diseases
Cancer
Cardiovascular disorders
Continuing Medical Education (CME)
Contraception and contraceptives
Dermatologic disorders
Diabetes
Dietary interventions
Editorials
Endocrinologic disorders
Exercise
Family practice/internal medicine
Fetal medicine
Gastrointestinal disorders
Genetics
Gynecologic disorders
Hematologic disorders
Hormones and hormone therapy
Infections

Infertility
Menopause
Menstrual disorders
Musculoskeletal disorders
Neurologic disorders
Obesity
Osteoporosis
Pain
Patient education
Quizzes
What you should know about...
Pharmacotherapy
Pregnancy
Preventive medicine
Psychiatric disorders
Pulmonary disorders
Sexuality
Sexually transmitted diseases
Surgical procedures
Urologic disorders

 

Adolescence
Chest pain in female adolescents. Feb:14—30

back to top


Alternative medicine
Hot flashes: nonprescription alternatives to ERT/HRT. Mar: 54—55
Managing perimenopausal symptoms: an integrative medicine approach. Aug:13—20
Natural progesterone. Apr:32—41
Soy and women's health. Dec:24—28

back to top


Breast diseases
Breast cancer. Oct:15—26
Common benign conditions of the breast. Oct:35—40
Contrary point of view: data regarding SERMs are inconclusive. Jan:17—26
Prophylactic effects shown: SERMs can prevent breast cancer. Jan:16—28

back to top


Cancer
Breast cancer. Oct:15—26
Colorectal cancer: does estrogen play a protective role— Nov:45—46
Contrary point of view: data regarding SERMs are inconclusive. Jan:17—26
Endometrial biopsy. Mar:47—51
Hereditary gynecologic malignancies. Feb:38—51
Hormone replacement and breast cancer. Dec(suppl):6—12
Melanoma. Jun:42—46
Prophylactic effects shown: SERMs can prevent breast cancer. Jan:16—28
Thyroid disorders in the elderly. Feb:52—57

back to top


Cardiovascular disorders
Aldosterone-receptor blocking agents. Oct(suppl):14—18
Cardiovascular implications of hormonal therapy. Dec(suppl):13—19
Chest pain in female adolescents. Feb:14—30
Coronary artery disease prevention in women. Jan:47—53
Hormone replacement and cardiovascular disease. Oct(suppl):5—9
Progestogens: new approaches. Oct(suppl):19—22
Recent findings in cardiovascular disease. Oct(suppl):3—4
Reducing CVD risk through lifestyle modification. Jun(suppl):44—48
The role of potassium. Oct(suppl):10—13

back to top


Continuing Medical Education (CME)
Aldosterone-receptor blocking agents. Oct(suppl):14—18
Chronic noncancer pain. Dec:29—34
Clinician—patient communication. Nov(suppl):8—10
Common benign conditions of the breast. Oct:35—40
Endometrial biopsy. Mar:47—51
Enhancing normal sexual function. Nov(suppl):15—18
Evaluation of hair loss in women. Apr:54—58
Hormone replacement and cardiovascular disease. Oct(suppl):5—9
Infertility, part 1: genetic causes in females. Aug:40—44
Melanoma. Jun:42—46
Menstrual migraine. Sep:35—40
Mifepristone. Jul:37—42
Multiple sclerosis, part 1: prompt diagnosis and early intervention. Nov:36—40
Pharmacotherapeutic options. Jul(suppl):10—14
Pre-conception management of women with type I diabetes. May:40—46
Progestogens: new approaches. Oct(suppl):19—22
Recent findings in cardiovascular disease. Oct(suppl):3—4
The role of potassium. Oct(suppl):10—13
Sexual dysfunction: current issues. Nov(suppl):4—7
Thyroid disorders in the elderly. Feb:52—57
Urinary incontinence: evaluation and -nonsurgical management. Jan:54—60
Vaginal atrophy. Nov(suppl):19—22
Women at risk. Jul(suppl):4—9

back to top


Contraception and contraceptives
Access to emergency contraception in the United States. Sep:8—13
Contraception in the perimenopause. Jun:33—40
Drospirenone. Nov:26—30
Emergency contraceptive pills. Mar:17—24
Equity in contraceptive prescription coverage. Jun:10—15
Mifepristone. Jul:37—42
Reduced-dose oral contraceptives. Sep:24—32
Transdermal contraception. Dec:13—14

back to top


Dermatologic disorders
Evaluation of hair loss in women. Apr:54—58
Melanoma. Jun:42—46

back to top


Diabetes
Diabetes management in the new millennium. May:10—11
ERT/HRT in diabetic women. Jan:33—34
Pre-conception management of women with type I diabetes. May:40—46

back to top


Dietary interventions
Coronary artery disease prevention in women. Jan:47—53
Fat metabolism throughout the life cycle. Apr:16—25
Hot flashes: nonprescription alternatives to ERT/HRT. Mar:54—55
Reducing CVD risk through lifestyle modification. Jun(suppl):44—48

back to top


Editorials
Access to emergency contraception in the United States. Sep:8—13
Bioterrorism and anthrax anxiety. Dec:8—9
The business of medicine. Mar:8
A call for clarity in breast care. Oct:8—11
Civility—it's to our advantage. Apr:10—12
Coding and compliance can't be ignored. Jan:8—13
Diabetes management in the new millennium. May:10—11
Equity in contraceptive prescription coverage. Jun:10—15
Evidence-based medicine, revisited. Nov:9
Meeting the needs of the aging female patient. Jun(suppl):9
Menopause and the generalist physician. Jul:10—11
New medicine, same old problems. Feb:8
Reflections. Aug:8

back to top


Endocrinologic disorders
Diabetes management in the new millennium. May:10—11
ERT/HRT in diabetic women. Jan:33—34
Evaluation of hair loss in women. Apr:54—58
Fat metabolism throughout the life cycle. Apr:16—25
Infertility, part 1: genetic causes in females. Aug:40—44
Infertility, part 2: genetic causes in males. Oct:31—34
Obesity and metabolic changes in aging women. Jun(suppl):39—43
Pre-conception management of women with type I diabetes. May:40—46
Thyroid disorders in the elderly. Feb:52—57

back to top


Exercise
Exercise during pregnancy. Apr:26—30
Medical concerns of endurance athletes. Jul:14—20
Reducing CVD risk through lifestyle modification. Jun(suppl):44—48

back to top


Family practice/internal medicine
The business of medicine. Mar:8
Civility—it's to our advantage. Apr:10—12
Coding and compliance can't be ignored. Jan:8—13
Deciphering the codes. Jan:37
Evidence-based medicine, revisited. Nov:9
New medicine, same old problems. Feb:8
Reflections. Aug:8

back to top


Fetal medicine
Bereavement in multiple birth, part 1: general considerations. Nov:31—35

back to top


Gastrointestinal disorders
Chest pain in female adolescents. Feb:14—30
Colorectal cancer: does estrogen play a protective role— Nov:45—46

back to top


Genetics
Hereditary gynecologic malignancies. Feb:38—51
Hormone replacement therapy. Dec(suppl):25—29
Infertility, part 1: genetic causes in females. Aug:40—44
Infertility, part 2: genetic causes in males. Oct:31—34
Women at risk. Jul(suppl):4—9

back to top


Gynecologic disorders
Endometrial biopsy. Mar:47—51
External genital warts. Nov:17—24
Female circumcision. Aug:23—32
Hereditary gynecologic malignancies. Feb:38—51
Infertility, part 1: genetic causes in females. Aug:40—44
Natural progesterone. Apr:32—41
Soy and women's health. Dec:24—28
Tubo-ovarian abscess. Jun:18—30
Vaginal atrophy. Nov(suppl):19—22
Vulvovaginal candidiasis. March(suppl):4—31
Work-up of bacterial vaginosis. Mar:25—30

back to top


Hematologic disorders
Medical concerns of endurance athletes. Jul:14—20

back to top


Hormones and hormone therapy
Cardiovascular implications of hormonal therapy. Dec(suppl):13—19
Colorectal cancer: does estrogen play a protective role— Nov:45—46
Common benign conditions of the breast. Oct:35—40
Contraception in the perimenopause. Jun:33—40
Contrary point of view: data regarding SERMs are inconclusive. Jan:17—26
Coronary artery disease prevention in women. Jan:47—53
Counseling for continuance: improving use of ERT/HRT. Dec:40—41
Drospirenone. Nov:26—30
Emergency contraceptive pills. Mar:17—24
Enhancing normal sexual function. Nov(suppl):15—18
Equity in contraceptive prescription coverage. Jun:10—15
ERT/HRT in diabetic women. Jan:33—34
ERT/HRT use in African-American women, part 1: implications for osteoporosis. May:34—39
Estrogen—androgen therapy. Sep:45—46
Hormone replacement and breast cancer. Dec(suppl):6—12
Hormone replacement and cardiovascular disease. Oct(suppl):5—9
Hormone replacement therapy. Dec(suppl): 25—29
Hot flashes: nonprescription alternatives to ERT/HRT. Mar:54—55
Hot flashes: prescription alternatives to ERT/HRT. Apr:61—62
Managing perimenopausal symptoms: an -integrative medicine approach. Aug:13—20
Menopause transition. Oct:45—46
Menstrual migraine. Sep:35—40
Natural progesterone. Apr:32—41
Pharmacotherapeutic options. Jul(suppl):10—14
Postmenopausal osteoporosis: pharmacologic options for prevention. Jul:47—48
Preservation of bone density in postmenopausal women. Dec:(suppl):20—24
Progestogens: new approaches. Oct(suppl):19—22
Prophylactic effects shown: SERMs can prevent breast cancer. Jan:16—28
Recent findings in cardiovascular disease. Oct(suppl):3—4
Reduced-dose oral contraceptives. Sep:24—32
Sexual dysfunction: current issues. Nov(suppl):4—7
Sleep and menopause. May:51—52
Sleep disorders in aging women. May:16—24
Soy and women's health. Dec:24—28
Surgically induced menopause. Feb:35—36
Transdermal contraception. Dec:13—14
Vaginal atrophy. Nov(suppl):19—22
Women at risk. Jul(suppl):4—9

back to top


Infections
External genital warts. Nov:17—24
HIV and women. Mar:38—45
More than a love bite. Nov:47
Tubo-ovarian abscess. Jun:18—30
Vulvovaginal candidiasis. March(suppl):4—31
Work-up of bacterial vaginosis. Mar:25—30

back to top


Infertility
Infertility, part 1: genetic causes in females. Aug:40—44
Infertility, part 2: genetic causes in males. Oct:31—34
Natural progesterone. Apr:32—41
"Occult" hysterectomy. Feb:62

back to top


Menopause
Aldosterone-receptor blocking agents. Oct(suppl):14—18
Colorectal cancer: does estrogen play a protective role— Nov:45—46
Confusional states in older women. Jun(suppl):16—25
Contraception in the perimenopause. Jun:33—40
Contrary point of view: data regarding SERMs are inconclusive. Jan:17—26
Coronary artery disease prevention in women. Jan:47—53
Counseling for continuance: improving use of ERT/HRT. Dec:40—41
Endometrial biopsy. Mar:47—51
Enhancing normal sexual function. Nov(suppl):15—18
ERT/HRT in diabetic women. Jan:33—34
ERT/HRT use in African-American women, part 1: implications for osteoporosis. May:34—39
Estrogen—androgen therapy. Sep:45—46
Fat metabolism throughout the life cycle. Apr:16—25
Hormone replacement and cardiovascular -disease. Oct(suppl):5—9
Hot flashes: nonprescription alternatives to ERT/HRT. Mar:54—55
Hot flashes: prescription alternatives to ERT/HRT. Apr:61—62
Managing perimenopausal symptoms: an integrative medicine approach. Aug:13—20
Menopause and mood. Aug:49—50
Menopause and sexual functioning. Jun:51—52
Menopause transition. Oct:45—46
Natural progesterone. Apr:32—41
Obesity and metabolic changes in aging women. Jun(suppl):39—43
Outpatient physical therapy. Jun(suppl):26—31
Overactive bladder in women. Jun(suppl):10—15
Pharmacotherapeutic options. Jul(suppl):10—14
Postmenopausal osteoporosis: pharmacologic options for prevention. Jul:47—48
Progestogens: new approaches. Oct(suppl):19—22
Prophylactic effects shown: SERMs can prevent breast cancer. Jan:16—28
Recent findings in cardiovascular disease. Oct(suppl):3—4
Reducing CVD risk through lifestyle modification. Jun(suppl):44—48
The role of potassium. Oct(suppl):10—13
Sleep and menopause. May:51—52
Sleep disorders in aging women. May:16—24
Soy and women's health. Dec:24—28
Surgically induced menopause. Feb:35—36
Urinary incontinence: evaluation and nonsurgical management. Jan:54—60
Vaginal atrophy. Nov(suppl):19—22
Women at risk. Jul(suppl):4—9

back to top


Menstrual disorders
Endometrial biopsy. Mar:47—51
Medical concerns of endurance athletes. Jul:14—20
Menopause transition. Oct:45—46
Menstrual migraine. Sep:35—40
Natural progesterone. Apr:32—41

back to top


Musculoskeletal disorders
Chest pain in female adolescents. Feb:14—30
Outpatient physical therapy. Jun(suppl):26—31

back to top


Neurologic disorders
Confusional states in older women. Jun(suppl):16—25
A contrary view: routine magnesium sulfate prophylaxis is unnecessary. Aug:35—39
Menstrual migraine. Sep:35—40
Multiple sclerosis, part 1: prompt diagnosis and early intervention. Nov:36—40
Multiple sclerosis, part 2: symptom -management. Dec:15—22
Seizure prophylaxis: magnesium sulfate advised in pre-eclamptic parturients. Aug:34—39
Sleep disorders in aging women. May:16—24

back to top


Obesity
Fat metabolism throughout the life cycle. Apr:16—25
Obesity and metabolic changes in aging women. Jun(suppl):39—43

back to top


Osteoporosis
ERT/HRT use in African-American women, part 1: implications for osteoporosis. May:34—39
Medical concerns of endurance athletes. Jul:14—20
Obesity and metabolic changes in aging women. Jun(suppl):39—43
Pharmacotherapeutic options. Jul(suppl):10—14
Postmenopausal osteoporosis: pharmacologic options for prevention. Jul:47—48
Preservation of bone density in postmenopausal women. Dec(suppl):20—24
Women at risk. Jul(suppl):4—9

back to top


Pain
Chronic noncancer pain. Dec:29—34
Menstrual migraine. Sep:35—40

back to top


Patient education
Asthma in women. S24:10—13
Bladder disorders. S25:8—11
Body art: the big picture. S30:25—26
Boost your beta-carotene. S28:22
Boost your vitamin C intake. S31:25
Breast cancer screening. S30:4—8
Breathing new life into old allergy care. S26:10—13
Cut calories from fast food. S24:26
Don't be afraid to ask: vaginal infections. S26:29—30
Eating for cancer prevention. S30:22
Eating healthy and light Falling into the season. S28:27—28
A heart-healthy and happy new year. S31:23—24
Holiday treats. S30:23—24
A taste of summer. S27:21—22
The epidemic of eating disorders. S30:9—12
Getaways in the golden years. S26:14—15
Hormones and health: living in balance. S25:3—7
Indoor allergies. S24:14—15
Is sex better from a bottle? S30:20—21
Is there an age limit for intimacy? S26:20—21
Is there sex after childbirth? S28:23—24
Keep your family healthy this winter. S31:4—8
Know the signs of preterm labor. S30:27—29
Living well with rheumatoid arthritis. S28:4—7
A look at mifepristone, the "abortion pill." S24:27—28
Menopause matters: a healthy opportunity. S27:17—18
Migraine: you can manage it. S24:4—8
Mistletoe for breast cancer. S27:23—24
Myth or miracle: fad diets exposed. S26:16—19
Non-prescription help for hot flashes. S30:18—19
Overcoming depression. S31:9—16
Overweight kids need our help. S30:13—17
Play it safe this season! S31:19—20
PMS at the next level. S26:22—23
Prescription alternatives for the treatment of hot flashes. S31:17—18
Quick action can minimize stroke damage. S24:16—19

back to top


Quizzes
Eating for cancer prevention. S30:22
Eating your way through menopause. S25:23—24
Nutrition for children. S27:20
Nutrition for the man in your life. S26:32
Nutrition through the ages: the senior years. S24:22
Relief for urinary tract infections. S28:12—13
Sex education: the early years. S27:19
Sexual dysfunction. S25:20—22
Shoulders, knees, and toes: understanding women—s injuries. S26:4—8
Slash your intake of saturated fat. S27:14
Slash your sugar intake. S26:31
SSRIs and sexual dysfunction. S31:21—22
Stalking the silent killer: ovarian cancer. S28:8—11
Step into great foot care. S27:15—16
A tailored approach to hormone replacement therapy. S25:15—19
Taking care of the skin you're in. S27:9—12
Taking control of PMS. S28:17—20
Talking with your health care provider about sexual -dysfunction. Nov(suppl):13—14
Using hormones in midlife. S28:25—26
Vanquishing varicose veins. S24:20—21
Vitamins, minerals, and bonding. S26:26—28

back to top


What you should know about...
Bacterial vaginosis. Dec:37—38
Cholesterol. Jun(suppl):49—50
Coronary artery disease. Jan:39—40
Emergency contraceptive pills. Mar:35—36
Female infertility. Aug:47—48
Genital warts. Nov:43—44
Hirsutism. S26:24—25.
Mammography. Oct:43—44
Menstrual migraine. Sep:43—44
Mifepristone. Jul:45—46
Sleep disorders. May:49—50
Thyroid disorders. Feb:31—32
Vaginal atrophy. Nov(suppl):11—12
What's new in contraception? S27:4—8
Your eyes and your hormones. S24:24—25

back to top


Pharmacotherapy
Aldosterone-receptor blocking agents. Oct(suppl):14—18
Antenatal corticosteroids. May:27—33
Chronic noncancer pain. Dec:29—34
Common benign conditions of the breast. Oct:35—40
Confusional states in older women. Jun(suppl):16—25
Enhancing normal sexual function. Nov(suppl):15—18
External genital warts. Nov:17—24
Hot flashes: prescription alternatives to ERT/HRT. Apr:61—62
Menstrual migraine. Sep:35—40
Multiple sclerosis, part 1: prompt diagnosis and early intervention. Nov:36—40
Multiple sclerosis, part 2: symptom management. Dec:15—22
Overactive bladder in women. Jun(suppl):10—15
Pharmacotherapeutic options. Jul(suppl):10—14
Postmenopausal osteoporosis: pharmacologic options for prevention. Jul:47—48
Psychotropic medications, part 1: use during pregnancy. Jul:27—32
The role of potassium. Oct(suppl):10—13
Sleep disorders in aging women. May:16—24
Tubo-ovarian abscess. Jun:18—30
Urinary incontinence: evaluation and nonsurgical management. Jan:54—60
Vaginal atrophy. Nov(suppl):19—22
Vulvovaginal candidiasis. March(suppl):4—31

back to top


Pregnancy
Antenatal corticosteroids. May:27—33
Bereavement in multiple birth, part 1: general considerations. Nov:31—35
A contrary view: routine magnesium sulfate prophylaxis is unnecessary. Aug:35—39
Exercise during pregnancy. Apr:26—30
HIV and women. Mar:38—45
Mifepristone. Jul:37—42
Natural progesterone. Apr:32—41
Pre-conception management of women with type I diabetes. May:40—46
Private or public: umbilical cord blood should be preserved and stored. Apr:42—53
Psychotropic medications, part 1: use during pregnancy. Jul:27—32
Public UCB banks. Apr:42—53
Seizure prophylaxis: magnesium sulfate advised in pre-eclamptic parturients. Aug:34—39

back to top


Preventive medicine
Coronary artery disease prevention in women. Jan:47—53
Emergency contraceptive pills. Mar:17—24
ERT/HRT in diabetic women. Jan:33—34
ERT/HRT use in African-American women, part 1: implications for osteoporosis. May:34—39
Postmenopausal osteoporosis: pharmacologic options for prevention. Jul:47—48
Pre-conception management of women with type I diabetes. May:40—46

back to top


Psychiatric disorders
Borderline personality disorder. Jul:22—26
Chest pain in female adolescents. Feb:14—30
Confusional states in older women. Jun(suppl):16—25
Meeting caregivers' health care needs. Jun(suppl):32—38
Menopause and mood. Aug:49—50
Psychotropic medications, part 1: use during pregnancy. Jul:27—32

back to top


Pulmonary disorders
Chest pain in female adolescents. Feb:14—30
Sleep disorders in aging women. May:16—24

back to top


Sexuality
Clinician—patient communication. Nov(suppl):8—10
Enhancing normal sexual function. Nov(suppl):15—18
Menopause and sexual functioning. Jun:51—52
Sexual dysfunction: current issues. Nov(suppl):4—7
Surgically induced menopause. Feb:35—36
Vaginal atrophy. Nov(suppl):19—22

back to top


Sexually transmitted diseases
HIV and women. Mar:38—45

back to top


Surgical procedures
Common benign conditions of the breast. Oct:35—40
Endometrial biopsy. Mar:47—51
External genital warts. Nov:17—24
Female circumcision. Aug:23—32
Melanoma. Jun:42—46
Tubo-ovarian abscess. Jun:18—30

back to top


Urologic disorders
Overactive bladder in women. Jun(suppl):10—15
Urinary incontinence: evaluation and nonsurgical management. Jan:54—60

back to top


[ Home | CME/CE | Product News | Author Guidelines ]
[ Editorial Boards | Reprints/Permissions | Archives | Circulation | Classifieds | Our Services ]


Copyright ©2000-2008 Quadrant HealthCom Inc., Parsippany, NJ, USA. All rights reserved. Unauthorized use prohibited. The information provided on femalepatient.com is for educational purposes only. Use of this Web site is subject to the medical disclaimer and privacy policy.